Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.67 |
| ▸ | RAB9A | P51151 | 4/20 | 0.67 |
| ▸ | PKM | P14618 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | TP53 | P04637 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | PGR | P06401 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | DRD1 | P21728 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.60 |
| ▸ | RELA | Q04206 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL11254296 | 0.99 | NPC1 (0.65) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| SCHEMBL11665938 | 0.89 | NPC1 (0.63) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| SCHEMBL8617302 | 0.86 | RAB9A (0.63) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| SCHEMBL11640452 | 0.84 | NPC1 (0.61) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| SCHEMBL1468602 | 0.84 | RAB9A (0.60) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| Indoprofen SCHEMBL27722126 | 0.84 | NPC1 (0.74) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| Propionic Acid SCHEMBL1764372 | 0.82 | NPC1 (0.76) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| SCHEMBL11641152 | 0.82 | NPC1 (0.59) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| SCHEMBL29874794 | 0.81 | NPC1 (1.00) | NPC1RAB9APKMSMN1; SMN2TP53 | |
| SCHEMBL4188221 | 0.81 | NPC1 (1.00) | NPC1RAB9APKMSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120083495-A1 | COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, | 2012-04-05 | — | — | US | disclosed |
| US-8110681-B2 | Compounds for the treatment of spinal muscular atrophy and other uses | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-02-07 | — | — | US | disclosed |
| US-8110681-B2 | Compounds for the treatment of spinal muscular atrophy and other uses | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-02-07 | — | — | US | disclosed |
| US-20090312323-A1 | COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HHS (US) | 2009-12-17 | — | — | US | disclosed |
| US-20090031435-A1 | SMA Therapy and Cell Based Assay | STOCKWELL BRENT R | 2009-01-29 | — | — | US | disclosed |
| WO-2006050451-A2 | METHODS AND COMPOSITIONS TO TREAT MOTOR NEURON DISEASE | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2006-05-11 | — | — | WO | disclosed |
| US-20040044063-A1 | SMA therapy and cell based assay for identifying therapies | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-03-04 | — | — | US | disclosed |
| EP-0380316-A2 | Preparation of alpha-methylareneacetic acids | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1990-08-01 | — | — | EP | disclosed |
| EP-0047674-B1 | NOVEL PROCESS FOR PREPARING ISOINDOLIN DERIVATIVES | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1984-02-29 | — | — | EP | disclosed |
| US-4400520-A | Novel process for preparing isoindoline derivatives | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1983-08-23 | — | — | US | disclosed |
| EP-0047674-A1 | Novel process for preparing isoindolin derivatives | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 1982-03-17 | — | — | EP | disclosed |
| US-4118504-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | Erba, Carlo (IT) | 1978-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083495-A1 | COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES | SMN1; SMN2, RNMT, CPT1B | NPC1 1076/4885RAB9A 1487/4885PKM 1256/4885 |
| US-20090312323-A1 | COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES | SMN1; SMN2, RNMT, CPT1B | NPC1 1202/4885RAB9A 1591/4885PKM 1033/4885 |
| US-20090031435-A1 | SMA Therapy and Cell Based Assay | SMN1; SMN2, RBM17, RBM22 | NPC1 3419/4885RAB9A 1840/4885PKM 1598/4885 |
| US-20040044063-A1 | SMA therapy and cell based assay for identifying therapies | SMN1; SMN2, RBM17, RBM22 | NPC1 3326/4885RAB9A 1912/4885PKM 1554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.